SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-202740
Filing Date
2011-07-29
Accepted
2011-07-29 15:48:00
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 566815
2 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE dex11.htm EX-11 26822
3 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12.htm EX-12 24465
4 RULE 13A-14(A) CERTIFICATION dex311.htm EX-31.1 9479
5 RULE 13A-14(A) CERTIFICATION dex312.htm EX-31.2 9689
6 SECTION 1350 CERTIFICATION dex32.htm EX-32 4412
  Complete submission text file 0001193125-11-202740.txt   5585830

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lly-20110630.xml EX-101.INS 1101141
8 XBRL TAXONOMY EXTENSION SCHEMA lly-20110630.xsd EX-101.SCH 34256
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lly-20110630_cal.xml EX-101.CAL 51145
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20110630_def.xml EX-101.DEF 97496
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20110630_lab.xml EX-101.LAB 272857
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20110630_pre.xml EX-101.PRE 205425
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 11997394
SIC: 2834 Pharmaceutical Preparations